Close
Nordic 9Nordic 9

RA Capital Management (investor - Private Equity)

United States racap.com
See something wrong or missing? Let us know
Offices:Boston

RA Capital Management is a Multi-Stage Investment Manager, dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics.

Average round investment:96.89M USD
Average number per year:5.6
Distribution: 2025 (7)2024 (9)2023 (3)2022 (3)2021 (6)
Portfolio companies: Denmark EvodiabioDenmark Sidera BioUnited Kingdom Artios Pharma See the entire list
Mostly invests in: Denmark Denmark (10) Health services (26)
See the entire list

Showing 3 of 28 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

RA Capital Management mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to RA Capital Management

Name Criteria
Israel 83North
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Robotics, Software Services
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Italy, France, Germany
  • Average number of deals per year: 4.9
  • Active last 12 months: Yes
United States Spark Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France, Germany
  • Average number of deals per year: 4.9
  • Active last 12 months: Yes
France Andera Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Robotics, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Italy, France, Germany
  • Average number of deals per year: 6.0
  • Active last 12 months: Yes
United States QED Investors
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Germany
  • Average number of deals per year: 4.6
  • Active last 12 months: Yes
United Kingdom Latitude
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Robotics, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, Germany
  • Average number of deals per year: 6.4
  • Active last 12 months: Yes
United States Goldman Sachs
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing, Robotics, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, France, Germany
  • Average number of deals per year: 6.7
  • Active last 12 months: Yes
Singapore Temasek
82%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Robotics, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, Italy, France, Germany
  • Average number of deals per year: 7.0
  • Active last 12 months: Yes
France Jeito Capital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, France, Germany
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
United States Battery Ventures
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Italy, France, Germany
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
United Kingdom SV Health Investors
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.3
  • Active last 12 months: Yes
Top